U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 13 results

TOCILIZUMAB

MORE DETAILS

I031V2H011

Protein
Status:
US Approved Rx (2013)
First approved in 2010
Class:
PROTEIN

CANAKINUMAB

MORE DETAILS

37CQ2C7X93

Protein
Status:
US Approved Rx (2009)
First approved in 2009
Class:
PROTEIN

GOLIMUMAB

MORE DETAILS

91X1KLU43E

Protein
Status:
US Approved Rx (2013)
First approved in 2009
Class:
PROTEIN

CERTOLIZUMAB PEGOL

MORE DETAILS

UMD07X179E

Protein
Status:
US Approved Rx (2008)
First approved in 2008
Class:
PROTEIN

ABATACEPT

MORE DETAILS

7D0YB67S97

Protein
Status:
US Approved Rx (2005)
First approved in 2005
Class:
PROTEIN

ADALIMUMAB

MORE DETAILS

FYS6T7F842

Protein
Status:
US Approved Rx (2021)
First approved in 2002
Class:
PROTEIN

ANAKINRA

MORE DETAILS

9013DUQ28K

Protein
Status:
US Approved Rx (2001)
First approved in 2001
Class:
PROTEIN

INFLIXIMAB

MORE DETAILS

B72HH48FLU

Protein
Status:
US Approved Rx (2019)
First approved in 1998
Class:
PROTEIN

ETANERCEPT

MORE DETAILS

OP401G7OJC

Protein
Status:
US Approved Rx (1998)
First approved in 1998
Class:
PROTEIN

RITUXIMAB

MORE DETAILS

4F4X42SYQ6

Protein
Status:
US Approved Rx (2020)
First approved in 1997
Class:
PROTEIN

Showing 1 - 10 of 13 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966